ALB vs BLFS · rev $1.74B vs rev $56.0M
Albemarle Corp (ALB) versus BioLife Solutions Inc (BLFS) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.
ALB currently screens at market cap $8.00B. BLFS currently screens at market cap $1.05B.
Not investment advice. Open the ALB and BLFS stock pages for the full models.
Not investment advice.